Alzamend Neuro ALZN
NASDAQ ALZN
$1.37 +0.05 (+3.79%)
At close: Oct 2, 2026 · 4:00 PM EDT

Alzamend Neuro (ALZN) Other Non Operating Income (2021)

Updated

Alzamend Neuro (ALZN) posted Other Non Operating Income of $4,000 for FY2022 (year ended Apr 30, 2022), down 93.6% from $62,418 in FY2021.

Analysis

Alzamend Neuro (ALZN) Other Non Operating Income (2021) Analysis & Trends

  • Business Quant data shows ALZN's Other Non Operating Income at $62,418 in FY2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Alzamend Neuro 6.61 Mn 6.61 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jan 31, 2021 62,418.00
API Access

Alzamend Neuro Other Non Operating Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-operating-income&ticker=ALZN&period=max&api_key=YOUR_API_KEY